Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies-Reference-Cited by-同舟云学术

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies

Published:2022-08-12 Issue:3 Volume:23 Page:142-158
ISSN:1474-1733
Container-title:Nature Reviews Immunology
language:en
Short-container-title:Nat Rev Immunol

Author:

Haynes Barton F.^ORCID,Wiehe Kevin,Borrow Persephone,Saunders Kevin O.,Korber Bette,Wagh Kshitij,McMichael Andrew J.,Kelsoe Garnett,Hahn Beatrice H.,Alt Frederick,Shaw George M.

Publisher

Springer Science and Business Media LLC

Subject

Energy Engineering and Power Technology,Fuel Technology

Link

https://www.nature.com/articles/s41577-022-00753-w.pdf

Reference254 articles.

1. Barré-Sinoussi, F. et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868–871 (1983).

2. Gallo, R. C. et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500–503 (1984).

3. Popovic, M., Sarngadharan, M. G., Read, E. & Gallo, R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224, 497–500 (1984).

4. Sarngadharan, M. G., Popovic, M., Bruch, L., Schüpbach, J. & Gallo, R. C. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 224, 506–508 (1984).

5. Saag, M. S. et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society-USA panel. JAMA 324, 1651–1669 (2020).

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single crystal, conformational, quantum reactivity, hirshfeld surface, molecular interactions, ADMET, and molecular docking investigations on HIV-1 site of 3-isopropyldiphenyl-1-(2-(thiophen-2yl)acetyl)piperidin-4-one;Journal of Molecular Structure;2024-12

2. Influence of membrane on the antigen presentation of the HIV-1 envelope membrane proximal external region (MPER);Current Opinion in Structural Biology;2024-10

3. Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A/B;Pharmaceutics;2024-09-13

4. HIV Vaccine Development at a Crossroads: New B and T Cell Approaches;Vaccines;2024-09-12

5. The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity;Journal of Virology;2024-09-09